Johan R Beetens

Title: The Innovations of Johan R Beetens

Introduction

Johan R Beetens is a notable inventor based in Zandhoven, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as 5-lipoxygenase inhibitors. His work is crucial in addressing leukotriene-mediated diseases, showcasing the impact of innovative research in medicine.

Latest Patents

Johan R Beetens holds a patent for a compound described as 4-[4- - 2-[2-(4-chlorophenyl)-2-(hydroxy or oxo)ethyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-5-methyl-3H-1,2,4-triazol-3-one. This compound has the formula ##STR1## wherein X represents C=O or CHOH. The patent outlines its use as a 5-lipoxygenase inhibitor, along with pharmaceutical compositions, processes for preparing said compounds and compositions, and a method of treating leukotriene-mediated diseases.

Career Highlights

Johan R Beetens is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development. His work at Janssen has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Johan has collaborated with esteemed colleagues such as Jan Heeres and Joseph H Mostmans. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Johan R Beetens exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for complex diseases. His work continues to inspire future advancements in medicine.